Boothbay Fund Management »

Kalaris Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $779k 92k 8.44

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A Put Option (PLTR)
Abivax Sa Sponsored Ads (ABVX)
Alphabet Cap Stk Cl C Put Option (GOOG)
Mineralys Therapeutics Put Option (MLYS)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Apple (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Kalaris Therapeutics

Samsara BioCapital
Rtw Investments
Paradigm Biocapital Advisors
Siren
Alyeska Investment Group
Ikarian Capital
Vanguard Group
ADAR1 Capital Management
Woodline Partners
Boothbay Fund Management
Raymond James Financial
Renaissance Technologies
Redmile Group
Geode Capital Management
683 Capital Management

View all funds holding Kalaris Therapeutics